Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetes Mellitus, Non-Insulin-Dependent, High Risk for Cardiovascular Event

In brief

This study is being carried out to determine the effect of dapagliflozin on cardiovacular outcomes when added to current background therapy in patients with type 2 diabetes with either established cardiovacular disease or cardiovascular risk factors.

Key facts

Study ID

NCT01730534

Run by

AstraZeneca

People needed

17190

Starts

2013-04-25

Expected to finish

2018-09-11

Last updated by the study team

2019-12-26

Who can join

Age: 40 and older, up to 130. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provision of informed consent prior to any study specific procedures
• Female or male aged ≥40 years
• Diagnosed with Type 2 Diabetes
• High Risk for Cardiovascular events

You may not qualify if…

• Diagnosis of Type 1 diabetes mellitus History of bladder cancer or history of radiation therapy to the lower abdomen or pelvis at any time
• Chronic cystitis and/or recurrent urinary tract infections
• Pregnant or breast-feeding patients

Where it is running

• Research Site — Athens, Alabama, United States
• Research Site — Birmingham, Alabama, United States
• Research Site — Birmingham, Alabama, United States
• Research Site — Mobile, Alabama, United States
• Research Site — Montgomery, Alabama, United States
• Research Site — Mesa, Arizona, United States
• Research Site — Mesa, Arizona, United States
• Research Site — Phoenix, Arizona, United States
• Research Site — Alhambra, California, United States
• Research Site — Bakersfield, California, United States
• Research Site — Greenbrae, California, United States
• Research Site — Huntington Park, California, United States
• Research Site — La Mesa, California, United States
• Research Site — Lomita, California, United States
• Research Site — Los Alamitos, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Newport Beach, California, United States
• Research Site — San Diego, California, United States
• Research Site — San Marino, California, United States
• Research Site — San Ramon, California, United States
• Research Site — Torrance, California, United States
• Research Site — Ventura, California, United States
• Research Site — Vista, California, United States
• Research Site — Alexander City, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.